Propeller Partners with AMC to Help Asthma and COPD Patients Better Manage Their Disease

Propeller Partners with AMC to Help Asthma and COPD Patients Better Manage Their Disease

Propeller Health recently announced its partnership with AMC Health to support patients with chronic obstructive pulmonary disease (COPD) and asthma to better manage their symptoms and reduce hospital emergency visits. The partnership, signed in January, is expected to begin this month with two commercial programs and a clinical research study exploring the adherence barriers at large health plans in the United States.

Chronic respiratory diseases such as COPD and asthma induce inflammation of the lung’s airways, making breathing difficult, a common reason for the costly admission to hospitals after emergency departmental visits.

This partnership will combine the expertise of Propeller in patient drug adherence and exacerbation, with AMC Health’s improved clinical efficiency and care coordination system. Propeller’s platform will integrate into AMC Health’s care management system to complement its clinical workflow. Other health plans across the U.S. will also be recruited to strengthen the system and provide efficient care for patients with COPD and asthma at reduced costs.

“Our commercial partnership begins with COPD, which is a challenging disease to manage, and it becomes increasingly difficult as it progresses. Most COPD patients are also burdened by comorbidities. Our partnership with AMC Health aims to help leading healthcare systems overcome these challenges through a more connected approach to care,” said Propeller Health CEO David Van Sickle in a press release “We are also excited about partnering in asthma, including new research made possible through this relationship.”

AMC Health is specialized in the delivery of healthcare through remote real-time monitoring of patients and virtual care coordination and expanding care beyond the conventional medical centers. Its approach was demonstrated through multiple studies of various size, duration, and multiple disease states with a number of results published in peer-reviewed journals.

“Our clinical, technology, and analytics expertise enables us to empower patients to confidently manage their health and connect them to the most appropriate intervention at the right time. This has a significant impact on patients with chronic health issues such as COPD and asthma,” said Nesim Bildirici, president and CEO of AMC Health. “Combining AMC Health’s 13 years of real-time virtual care experience with Propeller’s expertise in improving medication adherence supports improved health outcomes and care management efficiencies that substantially benefit patients and their care teams.”

Patients with chronic respiratory diseases use the Propeller system through more than 40 commercial programs in the U.S., and the system is compatible with most utilized inhaler devices. Propeller will supplement its business through this partnership, and new customers may either continue using its previous system or the new one established with AMC Health.

Propeller’s platform is designed to help COPD and asthma patients improve drug adherence, decrease symptoms recurrence, and predict exacerbations. Its tracking system integrates the combination of inhaler sensors, apps, analytics, education, and personal feedback, allowing it to detect patients’ needs and identify those at risk for intervention.

Leave a Comment